Stay updated on Switching to Cabotegravir and Rilpivirine: Clinical Trial
Sign up to get notified when there's something new on the Switching to Cabotegravir and Rilpivirine: Clinical Trial page.

Latest updates to the Switching to Cabotegravir and Rilpivirine: Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedAdded two new study locations: Ciudad Autonoma Buenos Aires, Argentina, C1405CKC and Guadajalara, Mexico, 44280. Removed previously listed Ciudad Autonoma de Bueno, Argentina, C1405CKC and Guadalajara, Mexico, 44280, indicating a replacement/update of site entries.SummaryDifference0.1%

- Check16 days agoChange DetectedPage revision updated from v3.6.2 to v3.6.3.SummaryDifference0.0%

- Check23 days agoChange DetectedAdded a new revision entry v3.6.2 and removed the previous v3.6.0 from the page's revision history. This indicates an incremental update to the page version.SummaryDifference0.0%

- Check38 days agoChange DetectedThe page now indicates recruitment has ceased and adds new guidance sections to help readers understand the study record and how to join, alongside a minor header/label update and revision tag.SummaryDifference0.2%

- Check45 days agoChange DetectedThe page revision label was updated from v3.5.4 to v3.5.5, representing a minor maintenance or content update; no changes to the study details are evident.SummaryDifference0.0%

- Check66 days agoChange DetectedThe page now shows a new Revision: v3.5.4 tag, replacing the previous Revision: v3.5.3. This indicates an update to the site's underlying software or documentation version, rather than content changes on the page itself.SummaryDifference0.0%

Stay in the know with updates to Switching to Cabotegravir and Rilpivirine: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Switching to Cabotegravir and Rilpivirine: Clinical Trial page.